Hospital Outcomes among COVID-19 Hospitalizations with Acute Ischemic Stroke: Cross-Sectional Study Results from California State Inpatient Database.
coronavirus
death
hospitalization
ischemic stroke
morbidity
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
01 Sep 2022
01 Sep 2022
Historique:
received:
20
06
2022
revised:
19
08
2022
accepted:
25
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) could be a risk factor for acute ischemic stroke (AIS) due to the altered coagulation process and hyperinflammation. This study examined the risk factors, clinical profile, and hospital outcomes of COVID-19 hospitalizations with AIS. This study was a retrospective analysis of data from California State Inpatient Database (SID) during 2019 and 2020. COVID-19 hospitalizations with age ≥ 18 years during 2020 and a historical cohort without COVID-19 from 2019 were included in the analysis. The primary outcomes studied were in-hospital mortality and discharge to destinations other than home. There were 91,420 COVID-19 hospitalizations, of which, 1027 (1.1%) had AIS. The historical control cohort included 58,083 AIS hospitalizations without COVID-19. Conditional logistic regression analysis showed that the odds of in-hospital mortality, discharge to destinations other than home, DVT, pulmonary embolism, septic shock, and mechanical ventilation were significantly higher among COVID-19 hospitalizations with AIS, compared to those without AIS. The odds of in-hospital mortality, DVT, pulmonary embolism, septic shock, mechanical ventilation, and respiratory failure were significantly higher among COVID-19 hospitalizations with AIS, compared to AIS hospitalizations without COVID-19. Although the prevalence of AIS was low among COVID-19 hospitalizations, it was associated with higher mortality and greater rates of discharges to destinations other than home.
Identifiants
pubmed: 36138913
pii: brainsci12091177
doi: 10.3390/brainsci12091177
pmc: PMC9496747
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurol. 2020 Aug;267(8):2185-2192
pubmed: 32436105
Cerebrovasc Dis. 2021;50(3):326-331
pubmed: 33774618
Stroke. 2020 Jul;51(7):2012-2017
pubmed: 32432994
Crit Care. 2020 Jun 18;24(1):360
pubmed: 32552865
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Stroke Vasc Neurol. 2020 Sep;5(3):279-284
pubmed: 32616524
Stroke. 2020 Jul;51(7):2228-2231
pubmed: 32432998
N Engl J Med. 2004 Dec 16;351(25):2611-8
pubmed: 15602021
Stroke. 2020 Aug;51(8):2540-2543
pubmed: 32466736
Neurology. 2020 Aug 18;95(7):e910-e920
pubmed: 32444493
Stroke. 2020 Jul;51(7):2002-2011
pubmed: 32432996
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
Stroke. 2020 Jul;51(7):2219-2223
pubmed: 32466735
Am J Cardiol. 2020 Sep 1;130:169-170
pubmed: 32690214
Stroke. 2021 Mar;52(3):905-912
pubmed: 33535779
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
JAMA Neurol. 2020 Jul 02;:
pubmed: 32614385
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Thromb Res. 2021 Jun;202:77-83
pubmed: 33773325
Int J Stroke. 2020 Oct;15(7):733-742
pubmed: 32501751